BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28395993)

  • 1. Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway.
    Sun J; Luo Q; Liu L; Yang X; Zhu S; Song G
    Toxicology; 2017 Jun; 384():1-10. PubMed ID: 28395993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-level shear stress promotes migration of liver cancer stem cells via the FAK-ERK1/2 signalling pathway.
    Sun J; Luo Q; Liu L; Song G
    Cancer Lett; 2018 Jul; 427():1-8. PubMed ID: 29678550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic mechano-growth factor E peptide promotes rat tenocyte migration by lessening cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signaling pathway.
    Zhang B; Luo Q; Mao X; Xu B; Yang L; Ju Y; Song G
    Exp Cell Res; 2014 Mar; 322(1):208-16. PubMed ID: 24434354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salinomycin inhibits hepatocellular carcinoma cell invasion and migration through JNK/JunD pathway-mediated MMP9 expression.
    Xu L; Wang T; Meng WY; Wei J; Ma JL; Shi M; Wang YG
    Oncol Rep; 2015 Mar; 33(3):1057-63. PubMed ID: 25522777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.
    Zhai B; Zhang X; Sun B; Cao L; Zhao L; Li J; Ge N; Chen L; Qian H; Yin Z
    Tumour Biol; 2016 Jun; 37(6):8047-55. PubMed ID: 26711788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
    Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
    Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salinomycin Suppresses Tumorigenicity of Liver Cancer Stem Cells and Wnt/Beta-catenin Signaling.
    Liu Q; Sun J; Luo Q; Ju Y; Song G
    Curr Stem Cell Res Ther; 2021; 16(5):630-637. PubMed ID: 31971116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways.
    Wu YJ; Neoh CA; Tsao CY; Su JH; Li HH
    Int J Mol Sci; 2015 Jul; 16(7):16469-82. PubMed ID: 26204832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway.
    Wang Y; Yuan L; Yang XM; Wei D; Wang B; Sun XX; Feng F; Nan G; Wang Y; Chen ZN; Bian H
    Clin Exp Metastasis; 2015 Jan; 32(1):39-53. PubMed ID: 25424030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-κB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
    Park JH; Cho YY; Yoon SW; Park B
    Int J Oncol; 2016 Sep; 49(3):1230-40. PubMed ID: 27573547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin inhibits proliferation and migration of human hepatocellular carcinoma cells via GAS7C and the N-WASP/FAK/F-actin pathway.
    Li D; Zhang B; Hu C
    Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):581-587. PubMed ID: 28475688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhinacanthin-C Extracted from Rhinacanthus nasutus (L.) Inhibits Cholangiocarcinoma Cell Migration and Invasion by Decreasing MMP-2, uPA, FAK and MAPK Pathways.
    Boueroy P; Saensa‑Ard S; Siripong P; Kanthawong S; Hahnvajanawong C
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3605-3613. PubMed ID: 30583689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin promotes mesenchymal stem cell migration and lessens cell stiffness via integrin β1, FAK, and ERK pathways.
    Zou C; Luo Q; Qin J; Shi Y; Yang L; Ju B; Song G
    Cell Biochem Biophys; 2013 Apr; 65(3):455-62. PubMed ID: 23086356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways.
    Yang M; Gu YY; Peng H; Zhao M; Wang J; Huang SK; Yuan XH; Li J; Sang JL; Luo Q; Huang C
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1037-47. PubMed ID: 25432142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
    Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM
    BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubus idaeus extract suppresses migration and invasion of human oral cancer by inhibiting MMP-2 through modulation of the Erk1/2 signaling pathway.
    Huang YW; Chuang CY; Hsieh YS; Chen PN; Yang SF; Shih-Hsuan-Lin ; Chen YY; Lin CW; Chang YC
    Environ Toxicol; 2017 Mar; 32(3):1037-1046. PubMed ID: 27322511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geraniin inhibits oral cancer cell migration by suppressing matrix metalloproteinase-2 activation through the FAK/Src and ERK pathways.
    Yeh CM; Hsieh MJ; Yang JS; Yang SF; Chuang YT; Su SC; Liang MY; Chen MK; Lin CW
    Environ Toxicol; 2019 Oct; 34(10):1085-1093. PubMed ID: 31184425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salinomycin causes migration and invasion of human fibrosarcoma cells by inducing MMP-2 expression via PI3-kinase, ERK-1/2 and p38 kinase pathways.
    Yu SM; Kim SJ
    Int J Oncol; 2016 Jun; 48(6):2686-92. PubMed ID: 27035160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of matrix stiffness relating integrin β1 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts.
    Wang C; Jiang X; Huang B; Zhou W; Cui X; Zheng C; Liu F; Bi J; Zhang Y; Luo H; Yuan L; Yang J; Yu Y
    BMC Cancer; 2021 Nov; 21(1):1276. PubMed ID: 34823500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.